Integrated strategies for drug discovery using mass spectrometry /

New strategies and techniques for today's fast-paced discovery processToday, the pressure is on for high-throughput approaches to accelerate the generation, identification, and optimization of molecules with desirable drug properties. As traditional methods of analysis become antiquated, new an...

Full description

Saved in:
Bibliographic Details
Other Authors: Lee, Mike S., 1960-
Format: Electronic eBook
Language:English
Published: Hoboken, N.J. : Wiley-Interscience, ©2005.
Subjects:
Online Access:CONNECT

MARC

LEADER 00000nam a22000004a 4500
001 in00006107307
006 m o d
007 cr cnu---unuuu
008 051006s2005 njua ob 001 0 eng d
005 20240125144151.9
020 |a 9780471721031 
020 |a 0471721026  |q (electronic bk.) 
020 |a 9780471721024  |q (electronic bk.) 
020 |a 047146127X  |q (cloth) 
020 |a 9780471461272  |q (cloth) 
020 |a 0471721034  |q (electronic bk.) 
024 7 |a 10.1002/0471721034  |2 doi 
035 |a (NhCcYBP)e80fa363d91f485b9a695405a0a7a4bb9780471721031 
035 |a 1wileyeba9780471721031 
040 |a NhCcYBP  |b eng  |c NhCcYBP 
050 4 |a RS189.5.S65  |b I55 2005eb 
060 4 |a 2005 J-429 
060 4 |a QV 25  |b I603 2005 
082 0 4 |a 615/.19  |2 22 
084 |a 35.27  |2 bcl 
084 |a 44.38  |2 bcl 
245 0 0 |a Integrated strategies for drug discovery using mass spectrometry /  |c [edited by] Mike S. Lee. 
260 |a Hoboken, N.J. :  |b Wiley-Interscience,  |c ©2005. 
300 |a 1 online resource (xvii, 550 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
500 |a Wiley EBA  |5 TMurS 
504 |a Includes bibliographical references and index. 
505 0 |a Miniaturized formats for efficient liquid chromatography mass spectrometry-based proteomics and therapeutic development / Gary A. Valaskovic and Neil Kelleher -- Mass-spectrometry-based drug screening assays for early phases in drug discovery / Marshall M. Siegel -- ESI-FTICR as a high throughput drug discovery platform / Kristin A. Sannes-Lowery [and others] -- Mass spectrometry-based proteomic approaches for disease diagnosis and biomarker discovery / Thomas P. Conrads [and others] -- Metabonomic applications in toxicity screening and disease diagnosis / John P. Shockcor and Elaine Holmes -- The central role of mass spectrometry in natural products discovery / Jeffrey R. Gilbert [and others]. 
505 0 |a Application of mass spectrometry to compound library generation, analysis, and management / Xueheng Cheng and Jill Hochlowski -- A combinatorial process for drug discovery / David S. Wagner [and others] -- Application of technological advances in biotransformation studies / Carmen L. Fernández-Metzler, Raju Subramanian and Richard C. King -- Applications of mass spectrometry for the characterization of reactive metabolites of drugs in discovery / Jim Wang [and others] -- Advances in high throughput quantitative drug discovery bioanalysis / Bradley L. Ackermann, Michael J. Berna and Anthony T. Murphy. 
505 0 |a New strategies for the implementation and support of bioanalysis in a drug metabolism environment / Walter A. Korfmacher -- An integrated LC-MS strategy for preclinical candidate optimization / Jonathan L. Josephs and Mark Sanders -- New approaches for method development and purification in lead optimization / Yining Zhao and David J. Semin -- High throughput metabolic and physicochemical property analysis / Edward H. Kerns and Li Di -- Organ perfusion and mass spectrometry / C. Gerald Curtis [and others] -- Sample preparation for drug discovery bioanalysis / David A. Wells -- Automation / John D. Laycock and Thomas Hartmann. 
588 0 |a Print version record. 
520 |a New strategies and techniques for today's fast-paced discovery processToday, the pressure is on for high-throughput approaches to accelerate the generation, identification, and optimization of molecules with desirable drug properties. As traditional methods of analysis become antiquated, new analytical strategies and techniques are necessary to meet sample throughput requirements and manpower constraints. 
650 0 |a Mass spectrometry. 
650 0 |a Drugs  |x Analysis. 
650 0 |a High throughput screening (Drug development) 
650 0 |a Drugs  |x Design. 
650 0 |a Pharmacokinetics. 
650 1 2 |a Drug Design 
650 1 2 |a Pharmaceutical Preparations  |x analysis 
650 2 2 |a Chromatography, Liquid  |x methods 
650 2 2 |a Pharmacokinetics 
650 2 2 |a Mass Spectrometry  |x methods 
650 2 |a Mass Spectrometry 
700 1 |a Lee, Mike S.,  |d 1960- 
730 0 |a WILEYEBA 
776 0 8 |i Print version:  |t Integrated strategies for drug discovery using mass spectrometry.  |d Hoboken, N.J. : Wiley-Interscience, ©2005  |z 047146127X  |w (DLC) 2005003235 
856 4 0 |u https://ezproxy.mtsu.edu/login?url=https://onlinelibrary.wiley.com/book/10.1002/0471721034  |z CONNECT  |3 Wiley  |t 0 
949 |a ho0 
975 |p Wiley UBCM Online Book All Titles thru 2023 
976 |a 6006612 
998 |a wi  |d z 
999 f f |s 5deb5c5c-3b32-44d8-8248-0e852e330fa9  |i 5deb5c5c-3b32-44d8-8248-0e852e330fa9  |t 0 
952 f f |a Middle Tennessee State University  |b Main  |c James E. Walker Library  |d Electronic Resources  |t 0  |e RS189.5.S65 I55 2005eb  |h Library of Congress classification